Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

por Andreozzi, Fabio, Dragani, Matteo, Quivoron, Cyril, Le Bras, Fabien, Assi, Tarek, Danu, Alina, Belhadj, Karim, Lazarovici, Julien, Cotteret, Sophie, Bernard, Olivier A., Ribrag, Vincent, Michot, Jean-Marie
Publicado 2023

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

por Quivoron, Cyril, Tarabay, Anthony, Michot, Jean-Marie, Pagès, Arnaud, Lecourt, Hélène, Aupérin, Anne, Danu, Alina, Lazarovici, Julien, Rossignol, Julien, Ghez, David, Dartigues, Peggy, Vergé, Véronique, Massard, Christophe, Camara-Clayette, Valérie, Ribrag, Vincent, Sarkozy, Clémentine
Publicado 2022

Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor

por Vargas-Valderrama, Alejandra, Ponsen, Anne-Charlotte, Le Gall, Morgane, Clay, Denis, Jacques, Sébastien, Manoliu, Tudor, Rouffiac, Valérie, Ser-le-Roux, Karine, Quivoron, Cyril, Louache, Fawzia, Uzan, Georges, Mitjavila-Garcia, Maria-Teresa, Oberlin, Estelle, Guenou, Hind
Publicado 2022

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers

por Khalife-Hachem, Sabine, Saleh, Khalil, Pasquier, Florence, Willekens, Christophe, Tarabay, Anthony, Antoun, Leony, Grinda, Thomas, Castilla-Llorente, Cristina, Duchmann, Matthieu, Quivoron, Cyril, Auger, Nathalie, Saada, Veronique, Delaloge, Suzette, Leary, Alexandra, Renneville, Aline, Antony-Debre, Ileana, Rosselli, Filippo, De Botton, Stéphane, Salviat, Flore, Marzac, Christophe, Micol, Jean-Baptiste
Publicado 2021

A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model

por Wang, Fang, Travins, Jeremy, Lin, Zhizhong, Si, Yaguang, Chen, Yue, Powe, Josh, Murray, Stuart, Zhu, Dongwei, Artin, Erin, Gross, Stefan, Santiago, Stephanie, Steadman, Mya, Kernytsky, Andrew, Straley, Kimberly, Lu, Chenming, Pop, Ana, Struys, Eduard A., Jansen, Erwin E. W., Salomons, Gajja S., David, Muriel D., Quivoron, Cyril, Penard-Lacronique, Virginie, Regan, Karen S., Liu, Wei, Dang, Lenny, Yang, Hua, Silverman, Lee, Agresta, Samuel, Dorsch, Marion, Biller, Scott, Yen, Katharine, Cang, Yong, Su, Shin-San Michael, Jin, Shengfang
Publicado 2016

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

por Popovici-Muller, Janeta, Lemieux, René M., Artin, Erin, Saunders, Jeffrey O., Salituro, Francesco G., Travins, Jeremy, Cianchetta, Giovanni, Cai, Zhenwei, Zhou, Ding, Cui, Dawei, Chen, Ping, Straley, Kimberly, Tobin, Erica, Wang, Fang, David, Muriel D., Penard-Lacronique, Virginie, Quivoron, Cyril, Saada, Véronique, de Botton, Stéphane, Gross, Stefan, Dang, Lenny, Yang, Hua, Utley, Luke, Chen, Yue, Kim, Hyeryun, Jin, Shengfang, Gu, Zhiwei, Yao, Gui, Luo, Zhiyong, Lv, Xiaobing, Fang, Cheng, Yan, Liping, Olaharski, Andrew, Silverman, Lee, Biller, Scott, Su, Shin-San M., Yen, Katharine
Publicado 2018